Drug Shortage Report for TEVA-ALMOTRIPTAN

Last updated on 2019-08-29 History
Report ID 19922
Drug Identification Number 02434849
Brand name TEVA-ALMOTRIPTAN
Common or Proper name ALMOTRIPTAN
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) ALMOTRIPTAN
Strength(s) 12.5MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 6
ATC code N02CC
ATC description ANTIMIGRAINE PREPARATIONS
Reason for shortage Requirements related to complying with good manufacturing practices.
Anticipated start date
Actual start date 2017-08-17
Estimated end date 2019-08-30
Actual end date 2019-08-28
Shortage status Resolved
Updated date 2019-08-29
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v22 2019-08-29 French Compare
v21 2019-08-29 English Compare
v20 2019-08-06 French Compare
v19 2019-08-06 English Compare
v18 2019-07-15 French Compare
v17 2019-07-15 English Compare
v16 2019-06-03 French Compare
v15 2019-06-03 English Compare
v14 2019-04-26 French Compare
v13 2019-04-26 English Compare
v12 2018-10-11 French Compare
v11 2018-10-11 English Compare
v10 2018-05-30 French Compare
v9 2018-05-30 English Compare
v8 2018-03-07 French Compare
v7 2018-03-07 English Compare
v6 2017-10-10 French Compare
v5 2017-10-10 English Compare
v4 2017-09-19 French Compare
v3 2017-09-19 English Compare

Showing 1 to 20 of 22